What is the EPS Bio Technology Corp. stock price forecast?

EPS Bio Technology Corp. is currently trading at $13.65. View real-time AI analysis on Alpha Lenz.

What is EPS Bio Technology Corp. insider trading activity?

View the latest insider trading data for EPS Bio Technology Corp. on Alpha Lenz.

What is EPS Bio Technology Corp.'s P/E ratio?

View EPS Bio Technology Corp.'s valuation metrics on Alpha Lenz.

EPS Bio Technology Corp.

TWSE · 4183

NT$13.65+0.00(+0.00%)

Ask about EPS Bio Technology Corp.'s future dividend policy...

Alpha Chat Insight

“EPS Bio Technology Corp.'s ROE is -2.7%. Explore profitability and growth together.”

Ask for details →

Company Overview

EPS Bio Technology Corp. is a healthcare technology company specializing in the development and manufacture of blood glucose monitoring systems. Founded in 2006 and headquartered in Hsinchu, Taiwan, the company serves both OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) markets, providing a range of solutions including glucose meters, test strips, and comprehensive diabetic self-monitoring systems. Its product portfolio features connectivity-enabled devices with technologies such as NFC and Bluetooth, supporting modern needs for data integration and digital health management. Focused on advancing diabetes care, EPS Bio Technology Corp. is recognized for its commitment to high-quality, user-friendly medical devices under brands like EASYMAX and MDT2 BLE. The company plays an important role in supplying both private label and branded solutions to healthcare providers and medical distributors, supporting chronic disease management and patient wellness. By leveraging ongoing research and a strong orientation towards environmental responsibility, EPS Bio Technology Corp. positions itself at the intersection of technology innovation and medical diagnostics within the broader healthcare sector.

Websitehttps://www.epsbio.com

SectorHealthcare

IndustryMedical Devices

Employees109

Company Statistics

FY 2025

Profile

N/AMarket Cap

NT$499.70MRevenue

0.00Shares Out

109Employees

Margins

17.42%Gross

2.04%EBITDA

-1.30%Operating

-1.93%Pre-Tax

-1.57%Net

Valuation

N/AP/E

N/AP/B

N/AEV/Sales

N/AEV/EBITDA

N/AP/FCF

Growth (CAGR)

2.54%Rev 3Yr

0.91%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-1.46%ROA

-2.69%ROE

-1.45%ROIC

Financial Health

NT$123.08MCash & Cash Equivalents

NT$129.06MNet Debt

89.70%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“EPS Bio Technology Corp.'s ROE is -2.7%. Explore profitability and growth together.”

Ask for details →

Frequently Asked Questions

EPS Bio Technology Corp. (ticker: 4183) is a company listed on TWSE in the Healthcare sector (Medical Devices). It has approximately 109 employees.

The current price is 13.65 with a P/E ratio of -x and P/B of -x.

ROE is -2.69% and operating margin is -1.30%. Annual revenue is $500M.